Optimal Treatment Strategy Based on for Pediatric AML

Clinical trial NCT02848183 · UNKNOWN

Trial details

NCT number: NCT02848183
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pediatric Acute Myeloid Leukemia

Start date: 2016-01-01
Primary completion: 2020-12-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.